cbdMD Announces Partnership with Medical Advisor, Dr. Lucille Vega
Charlotte, North Carolina--(Newsfile Corp. - June 22, 2023) - cbdMD (NYSE American: YCBD), one of the nation's leading providers of premium cannabidiol (CBD) products, is delighted to announce the appointment of Dr. Lucille Vega as their new medical advisor. This collaboration marks an exciting chapter for both parties, as they play a pivotal role in educating the public about the numerous benefits of CBD and cbdMD's commitment to quality and transparency.
As a brand that's renowned for its commitment to quality and innovation, cbdMD's comprehensive line of products spans across various categories and caters to a diverse range of consumer needs. By partnering with Dr. Vega, a highly qualified and passionate professional, the company aims to strengthen its position as a leader in the industry while providing customers with unparalleled expertise, education, and testimonials.
With an impressive background in family medicine and her adoration for medicinal cannabis, Dr. Lucille Vega merged the two within her concierge practice to help her patients with chronic conditions. Leading up to her partnership with cbdMD, Dr. Vega has been a true advocate for natural alternatives, dedicating her career to promoting wellness through evidence-based practices. Her CBD study was even presented to the F.D.A. in May 2019.
Dr. Vega's passion for transparency and commitment to rigorous scientific standards align perfectly with cbdMD's core values. "I am excited to align myself with a company whose high-quality standards meet my Ivy League expectations. Not only does cbdMD provide reliable products but they have their consumers' concerns at the forefront," shared Dr. Vega.
The partnership between cbdMD and Dr. Vega brings together a shared vision to empower individuals through unique medicinal alternatives and bringing light to the benefits of CBD. As part of the partnership, Dr. Vega will serve as a brand ambassador, appearing on social media, educational initiatives, research projects, industry events and more, all to promote the brand and educate fellow medical practitioners, media and consumers about the benefits of CBD and cbdMD's products.
cbdMD's Chief Marketing Officer Shannon Charles expressed her enthusiasm for the partnership stating, "We are thrilled to have Dr. Vega on board as our medical advisor. Her deep understanding of CBD, coupled with her dedication to education around the general industry, makes her an ideal advocate for our brand. We believe that her expertise will help us further our mission of providing high-quality CBD products, educating consumers about the many potential benefits, and empowering them to do great things."
For more information about cbdMD and their partnership with Dr. Lucille Vega, please visit cbdmd.com. Engage on social at @cbdmd.usa.
About cbdMD:
cbdMD, Inc. is one of the leading and most highly trusted and recognized hemp-derived cannabidiol (CBD) brands with a comprehensive line of U.S. produced, THC-free1 CBD products as well as Full Spectrum and Delta 9 THC products. The cbdMD brand currently includes high-quality, premium CBD products including tinctures, gummies, topicals, capsules, sleep aids and more. The Company's Paw CBD brand includes formulated pet products including tinctures, chews and topicals in varying strengths. To learn more about cbdMD and the complete line of products, please visit www.cbdmd.com, follow cbdMD on Instagram and Facebook or visit one of the thousands of retail outlets that carry cbdMD products.
Forward-Looking Statements:
This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified using words such as ''should,'' ''may,'' ''intends,'' ''anticipates,'' ''believes,'' ''estimates,'' ''projects,'' ''forecasts,'' ''expects,'' ''plans,'' and ''proposes.'' These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict. You are urged to carefully review and consider any cautionary statements, including but not limited to expectations on our partnership with Dr. Vega, and other disclosures, including the statements made under the heading "Risk Factors" in cbdMD, Inc.'s Annual Report on Form 10-K for the fiscal year ended September 30, 2022 as filed with the Securities and Exchange Commission (the "SEC") and our other filings with the SEC. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are generally outside the control of cbdMD, Inc. and are difficult to predict. cbdMD, Inc. does not undertake any duty to update any forward-looking statements except as may be required by law. The information which appears on our websites and our social media platforms, including, but not limited to, Instagram and Facebook, is not part of this press release.
1 THC-free is defined as below the level of detection using validated scientific analytical tools.
Contact Information:
cbdMD, Inc.
Ronan Kennedy, Interim CEO & CFO
+1 (704) 445-3064
IR@cbdmd.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/170731
